Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The somatostatin-2 receptor (SST2) is a target for peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NETs). By using epigenetic drugs, which can regulate gene transcription, PRRT efficacy may be further improved due to enhanced SST2 expression.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Klomp I
Authors: Klomp I, Dalm S, van Koetsveld P, Dogan-Oruç F, de Jong M,
Keywords: neuroendocrine tumors, bon-1, epigenetic, histone, histone deacetylase inhibitor, HDACi, upregulation, reversibility, somatostatin receptor-2, somatostatin,
Introduction: Everolimus increases PFS in patients with advanced NETs. Currently, no biomarkers are available for early selection of patients who will benefit from everolimus. Everolimus can reduce VEGF-A production by tumor cells.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Brouwers A, Van Asselt S, Oosting S, De Jong J, Lub-de Hooge M,
Keywords: neuroendocrine tumors, 89Zr-bevacizumab PET, VEGF-A, everolimus, biomarker,
Introduction: Tumor and microenvironment are important for tumor progression. Liver tumors can be hypervascular or hypovascular during the arterial phase of cross-sectional imaging.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: de Jong K
Authors: Van der Wal G, Gouw A, Moorlag H, Bulthuis M, Molema G,
Keywords: angiogenesis, VEGF, Angiopoietin, CT imaging,
#16 Endoglin as indicator of metastatic neuroendocrine tumors of the pancreas
Introduction: Neuroendocrine tumors of the pancreas are rare, highly vascularized tumors. Endoglin, a Transforming Growth Factor-β co-receptor, is a marker for angiogenic endothelial cells. Angiogenesis is required for tumor progression and the development of metastases. Recently, endoglin expression was found to be a prognostic marker in pancreatic carcinomas. However, the role of endoglin in neuroendocrine pancreatic tumors has so far not been studied.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Kuiper P, Verspaget H, de Jonge-Muller E, Hawinkels L, Biemond I,
Keywords: endoglin, pancreatic neuroendocrine tumor, angiogenesis, metastases,